Skip to content

Mehndi Dandwani, MD

NPI 1952922155ActiveIndividual· Internal Medicine, Hematology & Oncology· Iowa City, IA

Internal Medicine, Hematology & Oncology (MD) in Iowa City, Iowa, licensed in IA, with an NPI issued in April 2020. Part D covered 74 prescriptions written in 2024, 95% of them generic. Celgene Corporation reported $155.19 in payments in 2024, mostly food and beverage.

Overview

NPI1952922155
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedApr 29, 2020
Last updated in NPPESJul 15, 2024
Certified by providerJul 15, 2024

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (IA)

Part D prescriptions in 2024

Prescriptions (claims)74 · 75 30-day fills
Patients28
Total drug cost$3,979
Generic share95% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$155.19 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Celgene Corporation$155.191

What the 2024 payments were for

  • Food and Beverage$155.19 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Hematology & Oncology providers in Iowa City

All Internal Medicine, Hematology & Oncology providers in Iowa →